Therapeutic area
Diagnostics
Background info
Indication
Advantages
Intellectual property
Owner/lead
What the technology does
Polymerases capable of processing unnatural, xeno-nucleic acid (XNA) : alternative genetic polymers not found in nature
Advantage
Polymerases with the ability to process unnatural nucleic acids have been selected and evolved using a proprietary in vitro evolution technology, providing the tools to process a range of XNAs including ANA, FANA, CeNA, PNA and HNA.
Main application field
Various enzymes are available for processing of XNA, providing the tools for performance of selection and evolution of XNA aptamers with properties advantageous for diagnostic and therapeutic development
Usage
R&D tool
Status
Technology ready for evaluation and licensing
Intellectual Property
Patents filed 14-04-2011 (PCT/GB2011/000583), and 19-04-2012 (PCT/GB2013/050991).
Offering
Non-exclusive licence